Acetadote 6 GM per 30 ML Injection

RxCUI
582119
RxNorm name
Acetadote 6 GM per 30 ML Injection
Display name
Acetadote 6 GM per 30 ML Injection
Full name
Acetadote 6 GM per 30 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:56

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ACETADOTEACETYLCYSTEINECumberland Pharmaceuticals Inc.472f158a-5ab9-4308-8e49-1116e6ea3d392025-04-30Warnings, Adverse reactionsExact identifier
rxcui: 582119

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
472f158a-5ab9-4308-8e49-1116e6ea3d39Acetadote 6 GM per 30 ML InjectionSY17These highlights do not include all the information needed to use ACETADOTE safely and effectively. See full prescribing information for ACETADOTE. ACETADOTE (acetylcysteine) injection, for intravenous use Initial U.S. Approval: 200420250430
472f158a-5ab9-4308-8e49-1116e6ea3d3930 ML acetylcysteine 200 MG/ML Injection [Acetadote]SBD17These highlights do not include all the information needed to use ACETADOTE safely and effectively. See full prescribing information for ACETADOTE. ACETADOTE (acetylcysteine) injection, for intravenous use Initial U.S. Approval: 200420250430
472f158a-5ab9-4308-8e49-1116e6ea3d39Acetadote 6 GM in 30 ML InjectionPSN17These highlights do not include all the information needed to use ACETADOTE safely and effectively. See full prescribing information for ACETADOTE. ACETADOTE (acetylcysteine) injection, for intravenous use Initial U.S. Approval: 200420250430